AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2

Sitamyt M 50/500 Tablet

Prescription Icon
Prescription Required

Marketer

Novawock Pharma

Salt Composition

Sitagliptin (50mg) + Metformin (500mg)

Overview Sitamyt M 50/500 Tablet

Diabext Duo 50/500 tablets combine two medications to manage elevated blood glucose in type 2 diabetes. This dual action helps prevent serious diabetic complications like kidney disease and vision impairment, potentially lowering the risk of heart attack or stroke. Diabext Duo 50/500 may be used alone or with other diabetes treatments, and works most effectively alongside a healthy diet and regular physical activity. Dosage is individualized based on your health status, blood sugar readings, and other medications. Consuming it with food minimizes stomach upset. Consistent daily dosing at the same time maximizes efficacy; discontinue only under your doctor's guidance. Adherence to your prescribed diet and exercise plan is crucial. Lifestyle choices significantly impact diabetes control. Common side effects include diarrhea, nausea, vomiting, indigestion, headache, and throat irritation. Low blood sugar (hypoglycemia) is possible, especially with concurrent insulin or sulfonylurea use; learn how to identify and manage it. This medication isn't for everyone. Inform your doctor of any history of kidney, liver, or heart disease, pancreatic issues, or significant alcohol consumption before starting. Pregnant or breastfeeding individuals should seek medical advice. Other medications may interact with Diabext Duo 50/500; disclose all medications for safety. Alcohol should be limited due to its blood glucose-lowering effect. Your physician will monitor your kidney function and blood sugar levels throughout treatment.

Uses of Sitamyt M 50/500 Tablet

Managing type 2 diabetes

Major Benefits of Sitamyt M 50/500 Tablet:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Sitamyt M 50/500 Tablet with a meal.

Common Side effects of Sitamyt M 50/500 Tablet:

  • Decreased appetite
  • Vomiting
  • Upper respiratory tract infection
  • Hypoglycemia (low blood glucose level)
  • Abdominal bloating
  • Nausea
  • Diarrhea

How to use Sitamyt M 50/500 Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It's recommended to take the Sitamyt M 50/500 Tablet with a meal.

How Sitamyt M 50/500 Tablet works:

Sitamyt M 50/500 tablets combine sitagliptin and metformin to manage blood glucose levels. Sitagliptin enhances insulin production by the pancreas, improves the body's insulin utilization, and diminishes hepatic glucose output. Metformin, a biguanide, reduces liver glucose production, slows intestinal glucose absorption, and boosts insulin sensitivity. This dual action facilitates superior blood sugar regulation.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Sitamyt M 50/500 Tablet and alcohol is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

Use of Sitamyt M 50/500 Tablet during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to the fetus. A physician will assess the risks and benefits prior to prescribing. Consult your doctor for advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Use of Sitamyt M 50/500 Tablet while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with impaired kidney function should use Sitamyt M 50/500 Tablets cautiously, potentially requiring dosage modification. Physician consultation is essential. The medication is contraindicated in individuals with severely compromised renal function. Regular monitoring of kidney function is recommended during treatment.

LiverLiverUNSAFE

Patients with liver disorders should likely avoid Sitamyt M 50/500 Tablets due to potential safety concerns. Medical advice is recommended.

What if you forget to take Sitamyt M 50/500 Tablet :

Should you forget a Sitamyt M 50/500 Tablet dose, take it immediately. But, if your next dose is nearly due, omit the missed dose and resume your usual dosing regimen. Never take a double dose.

Facts to Know About Sitamyt M 50/500 Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Sitamyt M 50/500 Tablet

Sitamyt M 50/500 Tablet combines sitagliptin and metformin to manage type 2 diabetes in adults. It helps control blood sugar when used with diet and exercise. Metformin reduces liver glucose production and improves insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Prolonged Sitamyt M 50/500 Tablet use can lead to vitamin B12 deficiency by hindering its absorption. This deficiency may cause anemia, nerve damage (manifested as tingling, numbness in extremities, weakness, and urinary issues), and cognitive changes (including ataxia). To mitigate these risks, annual supplemental vitamin B12 is recommended by some researchers.
Sitamyt M 50/500 Tablet may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory tract infections. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Sitamyt M 50/500 Tablets are contraindicated in patients with allergies to any ingredient, and those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Sitamyt M 50/500 Tablet with alcohol is unsafe and may heighten the risk of lactic acidosis.
Store this medication in its original, tightly closed container, as directed on the label. Discard any unused medication; keep it out of reach of children, pets, and others.
Sitamyt M 50/500 Tablet can cause lactic acidosis (MALA, or Metformin-associated lactic acidosis), a serious medical emergency resulting from excessive blood lactic acid. This rare side effect necessitates caution in patients with kidney disease, the elderly, or those who consume large amounts of alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Sitagliptin + Metformin and seek immediate medical attention.
Sitamyt M 50/500 Tablet combines sitagliptin and metformin to manage type 2 diabetes in adults. It helps control blood sugar levels when used with a healthy diet and exercise. Metformin reduces liver glucose production and improves insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Sitamyt M 50/500 Tablet may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory tract infections. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Sitamyt M 50/500 Tablets are contraindicated in patients with known allergies to its components or excipients, and in those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Sitamyt M 50/500 Tablet with alcohol is unsafe and may heighten the risk of lactic acidosis.
Sitamyt M 50/500 Tablets can cause lactic acidosis, a serious medical emergency resulting from excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare side effect necessitates avoiding the medication in patients with kidney disease, the elderly, or those who consume significant alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If these symptoms occur, discontinue Sitagliptin + Metformin and seek immediate medical attention.
Prolonged Sitamyt M 50/500 Tablet use can lead to vitamin B12 deficiency by hindering its absorption. This deficiency may cause anemia, nerve damage (manifesting as numbness, tingling in extremities, weakness, urinary issues, cognitive changes, and ataxia), if left unaddressed. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, as directed on the label or packaging. Discard any unused medication and keep it out of reach of children, pets, and others.
Sitamyt M 50/500 tablets combine sitagliptin and metformin to treat type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Sitamyt M 50/500 Tablet may cause common side effects such as low blood sugar (hypoglycemia), taste changes, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use may also result in vitamin B12 deficiency.
Sitamyt M 50/500 Tablets are contraindicated in patients with known allergies to its components or excipients, and those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Sitamyt M 50/500 Tablet with alcohol is unsafe and may heighten the risk of lactic acidosis.
Sitamyt M 50/500 Tablet can cause lactic acidosis, a serious medical emergency resulting from excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare side effect necessitates avoiding the medication in patients with kidney disease, the elderly, or those who consume significant alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If these occur, discontinue Sitagliptin + Metformin and seek immediate medical attention.
Prolonged Sitamyt M 50/500 Tablet use can lead to vitamin B12 deficiency by impairing its absorption. This deficiency may cause anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and balance difficulties (ataxia). To mitigate these risks, supplemental vitamin B12 is recommended annually by some researchers.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Dispose of any unused medication safely and prevent access by children, pets, and others.
Sitamyt M 50/500 Tablet
125
MRP 145
13% off